Amarna Therapeutics Strengthens Manufacturing Collaboration with NorthX Biologics
Amarna Therapeutics has entered into a formal agreement with NorthX Biologics to support the continued development and manufacturing of Nimvec™ AM510, a gene therapy candidate aimed at treating
Theratechnologies to Be Acquired by Future Pak
Theratechnologies Inc., a commercial-stage biopharmaceutical company, has entered into a binding arrangement to be acquired by CB Biotechnology, LLC, an affiliate of contract manufacturer Future
Almac Completes Cold Chain Expansion at Craigavon HQ
Almac Clinical Services, part of the Almac Group, has announced the completion of a multi-million-pound expansion of its cold chain capabilities at its global headquarters
Circio Expands Stockholm Lab to Advance Circular RNA Drug Development
Circio Holding ASA, a biotechnology company focused on circular RNA technology, has expanded its laboratory operations in Stockholm, Sweden. The new facility at Novum Labs
Biosynth Opens Expanded GMP Bioconjugation Facility in Berlin
Biosynth has officially opened its expanded GMP bioconjugation facility in Berlin, further strengthening its global manufacturing network and CDMO services. The upgrade enhances production of conjugate
European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality
At CDMO Live 2025, Elisabeth Stampa (Medicines for Europe), Elena Barboni (Flamma) and Agneta Larhed (RegSmart Life Science) discussed how Europe’s stringent new regulations could
BioSpring Breaks Ground on One of World’s Largest Nucleic Acid API Sites in Germany
BioSpring has officially launched construction of a major new manufacturing site on the Offenbach Innovation Campus in Germany, in a move that will position the company
WuXi XDC Achieves Mechanical Completion of 25,000 m² Singapore Bioconjugate Site
WuXi XDC, a global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate sector, has announced the mechanical completion of its new manufacturing
Merck KGaA Completes Acquisition of SpringWorks Therapeutics
Merck KGaA, Darmstadt, Germany has announced the closing of its $3.4 billion (approximately €3 billion) acquisition of SpringWorks Therapeutics, Inc., a U.S.-based biopharmaceutical company focused on
Axplora Invests €35M to Expand Farmabios Site in Italy
Axplora has announced a €35 million expansion of its Farmabios facility in Gropello Cairoli, Italy, marking a continued commitment to growth and innovation in active pharmaceutical
Stay ahead of trends and best practices
